Profound Medical EBITDA Margin Growth & History (PROF)

Profound Medical's ebitda margin was −252.79% for fiscal 2025.

View full Profound Medical company overview

Profound Medical annual ebitda margin history

Profound Medical annual ebitda margin

Fiscal yearPeriod endedEBITDA marginChange (percentage points)
20252025-12-31−252.79%+77.05 pp
20242024-12-31−329.84%+136.43 pp
20232023-12-31−466.27%−9.42 pp
20222022-12-31−456.85%−43.46 pp
20212021-12-31−413.39%−176.19 pp
20202020-12-31−237.20%+83.67 pp
20192019-12-31−320.87%

Profound Medical ebitda margin trends

Over the last five fiscal years, Profound Medical's ebitda margin decreased from −237.20% to −252.79%, a change of −15.59 percentage points. The latest reported quarter, Q2 2026, shows −440.23%.

About the metric

What EBITDA margin means

EBITDA margin measures EBITDA as a percentage of revenue. It can help compare operating profitability over time, but it excludes capital intensity, financing costs, taxes, and other items and is generally unsuitable for financial companies.

Calculation and source

How EBITDA margin is calculated

TickerStat calculates EBITDA margin as EBITDA divided by positive reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Profound Medical source filings ↗

Community posts

It’s quiet here.

No posts about PROF yet. Start the conversation.

Write the first post